Stimulant Abuse
7
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Substance Misuse To Psychosis for Stimulants
rTMS for Stimulant Use Disorders
Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
Integrated BA and HIV RR Counseling for MSM With Stimulant Abuse
Pepped on Pre-exposure Prophylaxis (PrEP): A Counseling and Problem-Solving PrEP Adherence Intervention for Stimulant Using Men Who Have Sex With Men (MSM).
The Discriminative Effects of Tramadol in Humans